127 related articles for article (PubMed ID: 12381481)
1. IUD use and the risk of endometrial cancer.
Benshushan A; Paltiel O; Rojansky N; Brzezinski A; Laufer N
Eur J Obstet Gynecol Reprod Biol; 2002 Nov; 105(2):166-9. PubMed ID: 12381481
[TBL] [Abstract][Full Text] [Related]
2. Ovulation induction and risk of endometrial cancer: a pilot study.
Benshushan A; Paltiel O; Brzezinski A; Tanos V; Barchana M; Shoshani O; Gordon L; Tsur L; Schenker JG
Eur J Obstet Gynecol Reprod Biol; 2001 Sep; 98(1):53-7. PubMed ID: 11516800
[TBL] [Abstract][Full Text] [Related]
3. Intrauterine device use and endometrial cancer risk.
Sturgeon SR; Brinton LA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Lurain JR
Int J Epidemiol; 1997 Jun; 26(3):496-500. PubMed ID: 9222773
[TBL] [Abstract][Full Text] [Related]
4. Intrauterine device use and risk of endometrial cancer.
Parazzini F; La Vecchia C; Moroni S
Br J Cancer; 1994 Oct; 70(4):672-3. PubMed ID: 7917915
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptive and IUD use and endometrial cancer: a population-based case-control study in Shanghai, China.
Tao MH; Xu WH; Zheng W; Zhang ZF; Gao YT; Ruan ZX; Cheng JR; Gao J; Xiang YB; Shu XO
Int J Cancer; 2006 Nov; 119(9):2142-7. PubMed ID: 16823853
[TBL] [Abstract][Full Text] [Related]
6. Intra-uterine contraception and the risk of endometrial cancer.
Castellsagué X; Thompson WD; Dubrow R
Int J Cancer; 1993 Jul; 54(6):911-6. PubMed ID: 8335399
[TBL] [Abstract][Full Text] [Related]
7. Endometrial cancer in relation to intra-uterine device use.
Hill DA; Weiss NS; Voigt LF; Beresford SA
Int J Cancer; 1997 Jan; 70(3):278-81. PubMed ID: 9033627
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of intrauterine device use and risk of endometrial cancer.
Beining RM; Dennis LK; Smith EM; Dokras A
Ann Epidemiol; 2008 Jun; 18(6):492-9. PubMed ID: 18261926
[TBL] [Abstract][Full Text] [Related]
9. Invasive cervical cancer and intrauterine device use.
Lassise DL; Savitz DA; Hamman RF; Barón AE; Brinton LA; Levines RS
Int J Epidemiol; 1991 Dec; 20(4):865-70. PubMed ID: 1800424
[TBL] [Abstract][Full Text] [Related]
10. Intrauterine devices and endometrial cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Rosenblatt KA; Thomas DB
Contraception; 1996 Dec; 54(6):329-32. PubMed ID: 8968660
[TBL] [Abstract][Full Text] [Related]
11. Should endometrial hyperplasia be regarded as a reason for abnormal uterine bleeding in users of the intrauterine contraceptive device?
Ozalp S; Kabukcuoglu S; Tanir HM
Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):17-20. PubMed ID: 12725671
[TBL] [Abstract][Full Text] [Related]
12. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
[TBL] [Abstract][Full Text] [Related]
13. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting intrauterine contraceptive device performance. I. Endometrial cavity length.
Hasson HM; Berger GS; Edelman DA
Am J Obstet Gynecol; 1976 Dec; 126(8):973-81. PubMed ID: 998687
[TBL] [Abstract][Full Text] [Related]
15. Endometrial reaction to intrauterine device in pregnancy.
Ezra Y; Birkenfeld A; Levij IS
Gynecol Obstet Invest; 1989; 28(1):5-7. PubMed ID: 2777135
[TBL] [Abstract][Full Text] [Related]
16. Compelling reasons for recommending IUDs to any woman of reproductive age.
Arias RD
Int J Fertil Womens Med; 2002; 47(2):87-95. PubMed ID: 11991435
[TBL] [Abstract][Full Text] [Related]
17. Long term effects of IUD on the human endometrium. Histologic, histochemical and ultrastructural studies.
Lee YB; Kim CS; Ro JY; Kwak HM; Song CH
Yonsei Med J; 1983; 24(2):141-8. PubMed ID: 6679680
[TBL] [Abstract][Full Text] [Related]
18. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
[TBL] [Abstract][Full Text] [Related]
19. A population-based study of endometrial cancer and familial risk in younger women. Cancer and Steroid Hormone Study Group.
Gruber SB; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):411-7. PubMed ID: 8781735
[TBL] [Abstract][Full Text] [Related]
20. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
Clark DA; Wang S; Rogers P; Vince G; Affandi B
Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
